Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nissin Pharmaceutical Co., Ltd. is a leading Japanese pharmaceutical company primarily focused on the development, manufacturing, and distribution of generic drugs. Headquartered in Yamagata Prefecture, the company has established itself as a key player in the Japanese domestic market since its founding in 1946. Beyond its own product portfolio, Nissin Pharmaceutical operates as a comprehensive Contract Development and Manufacturing Organization (CDMO), offering expertise in various formulations including oral solids and injectables. The company maintains state-of-the-art manufacturing facilities that adhere to strict global Good Manufacturing Practice (GMP) standards. Their therapeutic focus is broad, covering cardiovascular, metabolic, and central nervous system disorders, among others. By providing high-quality, cost-effective generic alternatives, Nissin Pharmaceutical plays a vital role in supporting the sustainability of the Japanese healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nissin Pharmaceutical.